6 Analysts Assess Amylyx Pharma: What You Need To Know
6 Analysts Assess Amylyx Pharma: What You Need To Know
6位分析師評估Amylyx Pharma：你需要知道的
Across the recent three months, 6 analysts have shared their insights on Amylyx Pharma (NASDAQ:AMLX), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 0 | 2 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 1 | 0 | 0 |
| 3M Ago | 2 | 0 | 1 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $6.33, a high estimate of $8.00, and a low estimate of $3.00. A decline of 1.09% from the prior average price target is evident in the current average.
Interpreting Analyst Ratings: A Closer Look
The standing of Amylyx...
登入免費觀看全文
登入/註冊